Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:I-224-I-228
doi: 10.1161/CIRCULATIONAHA.104.525378
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seeburger, J.
Right arrow Articles by Aebert, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seeburger, J.
Right arrow Articles by Aebert, H.
Related Collections
Right arrow CV surgery: other

(Circulation. 2005;112:I-224 – I-228.)
© 2005 American Heart Association, Inc.


Myocardial Protection and Vascular Biology

Gene Expression Changes in Leukocytes During Cardiopulmonary Bypass Are Dependent on Circuit Coating

Joerg Seeburger, BSc; Jan Hoffmann, MSc; Hans Peter Wendel, PhD; Gerhard Ziemer, MD; Hermann Aebert, MD

From the Department of Thoracic, Cardiac, and Vascular Surgery, Eberhard Karls University, Tuebingen, Germany.

Correspondence to Dr Hermann Aebert, Department of Thoracic, Cardiac, and Vascular Surgery, Eberhard Karls University, Hoppe-Seyler-Str 3, 72076 Tuebingen, Germany. E-mail hermann.aebert{at}med.uni-tuebingen.de

Background— Cardiopulmonary bypass (CPB) results in a systemic inflammatory response. Leukocytes play a crucial role in inflammatory reactions. Their gene expression profile in the context of CPB is unknown.

Methods and Results— In a prospective, randomized, and double-blind clinical trial, 12 male patients underwent elective coronary artery bypass grafting with either heparin-coated (group H) or protein-coated (group P) CPB circuits. Oligonucleotide microarray analyses of 22 283 genes were performed on circulating leukocytes, collected immediately before surgery and 6 hours after CPB. Microarray results were validated with real-time polymerase chain reaction. All patients had uneventful surgery, and no significant differences between groups were observed during the clinical course. Multiple statistical analyses with different methods were performed. Compared with preoperative expression at a threshold value of P<0.01, postoperative expression revealed 814 upregulated and 1187 downregulated genes in group H compared with 99 upregulated and 231 downregulated in group P (P<0.001). Fifty genes exhibited a >4-fold increase and 27 exhibited a >4-fold decrease in group H, whereas only 7 genes exhibited upregulation and 7 revealed downregulation in group P. Microarray-pathway-profile-finder analyses determined 1405 upregulated and 1454 downregulated pathways in group H compared with 552 upregulated and 818 downregulated pathways in group P (P<0.01). Pathways related to inflammatory response exhibited highest z scores in group H, reflecting cellular inflammatory activation.

Conclusions— Heparin coating resulted in a more profound alteration in leukocyte gene expression when compared with protein coating. Microarray analyses present an innovative approach for the evaluation and understanding of inflammatory reactions associated with CPB.


Key Words: cardiopulmonary bypass • genes • inflammation • leukocytes